AP1-Luc/EF1α-mCherry Reporter Cell Line - T24

The AP1-Luc/EF1α-mCherry Reporter Cell Line - T24 is a sophisticated dual-reporter platform developed from the human bladder transitional cell carcinoma T24 line. It incorporates a firefly luciferase reporter gene driven by a promoter containing multiple AP-1 (Activator Protein 1) response elements, enabling the precise measurement of AP-1-mediated transcriptional activity. To ensure experimental accuracy, the cell line also features constitutive mCherry red fluorescent protein expression under the control of the EF1α promoter. This setup serves as a robust internal control, allowing for normalization of the luciferase signal against cell number and viability. The integration of these reporters into the T24 genome provides a stable and consistent model for studying the signaling dynamics of the JNK/MAPK pathways in a human cancer context.

This reporter cell line is primarily utilized for the high-throughput screening of small molecule inhibitors or biological modulators that influence the AP-1 signaling cascade. Since AP-1 is a key transcription factor complex involved in regulating cellular proliferation, transformation, and stress responses, this tool is critical for drug discovery in oncology and inflammatory diseases. Researchers can quantify the activation or inhibition of the pathway by measuring bioluminescence after treatment with various stimuli, such as growth factors or cytokines. Additionally, the constitutive mCherry signal enables longitudinal tracking of cell populations in complex assays, including co-culture systems and in vivo xenograft models. By facilitating both quantitative biochemical readouts and qualitative imaging data, the AP1-Luc/EF1α-mCherry T24 cell line significantly streamlines the validation of therapeutic targets and the evaluation of drug efficacy in preclinical research environments.